Mohit Manrao: Let’s unite our voices and push to accelerate progress in eliminating cancer as a cause of death
Mohit Manrao, SVP and Head of US Oncology at AstraZeneca, shared a post on LinkedIn:
“April is Cancer Control Month!
At AstraZeneca, we recognize the vital role of public-private partnerships in accelerating progress in the fight against cancer. With The White House declaring this month to honor the countless Americans impacted by cancer, we stand together with oncology leaders and propose bold and immediate actions for the new administration.
Our recommendations focus on enhancing the future for patients and society, ensuring that we build on the incredible progress we’ve made and continue to innovate in cancer care.
Nearly 1 in 3 Americans will be diagnosed with cancer in their lifetime. Together, we can change this statistic.
Dive deeper into our insights in the latest article from U.S. News and World Report.
Let’s unite our voices and push to accelerate progress in eliminating cancer as a cause of death!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023